Latest News

  • Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring Read More
  • Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230 Read More
  • Alkermes to Host Conference Call to Discuss Third Quarter 2019 Financial Results Read More

Investors

Working at Alkermes